These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 695155)

  • 1. Reduction in urinary oxalate values by allopurinol.
    Scott R; Paterson PJ; Smith M; Mathieson A
    Urology; 1978 Aug; 12(2):212-4. PubMed ID: 695155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of allopurinol on urinary oxalate excretion in stone formers.
    Scott R; Paterson PJ; Mathieson A; Smith M
    Br J Urol; 1978 Dec; 50(7):455-8. PubMed ID: 753494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol in the recurrence prevention of calcium oxalate lithiasis.
    Brien G; Bick C
    Eur Urol; 1977; 3(1):35-6. PubMed ID: 837952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of effect of allopurinol on oxalate excretion by stone patients on random and controlled diets.
    Urivetzky M; Braverman S; Motola JA; Smith AD
    J Urol; 1990 Jul; 144(1):97-8. PubMed ID: 2359187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary oxalate levels are not affected by dietary purine intake or allopurinol.
    Morris GS; Simmonds HA; Toseland PA; Van Acker KJ; Davies PM; Stuchbury JH
    Br J Urol; 1987 Oct; 60(4):292-300. PubMed ID: 3690198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J; Zechner O
    Eur Urol; 1988; 15(3-4):227-9. PubMed ID: 3215256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined administration of calcium and citrate reduces urinary oxalate excretion].
    Ito H
    Hinyokika Kiyo; 1991 Oct; 37(10):1107-10. PubMed ID: 1755399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected medical aspects of the problem of calcium oxalate stones: a review.
    Rose GA
    J R Soc Med; 1982 Nov; 75(11):897-9. PubMed ID: 6754926
    [No Abstract]   [Full Text] [Related]  

  • 13. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxalate loading test for outpatients with calcium oxalate stones].
    Kato M
    Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of allopurinol in the prevention of recurrent calcium oxalate stones].
    Sonoda T; Koide T; Oka T; Sakaguchi H; Itatani H; Ohkawa T; Ebisuno S; Morimoto S; Yoshida O; Okada Y
    Hinyokika Kiyo; 1985 Nov; 31(11):2071-9. PubMed ID: 4091144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical studies on bilharzial and nonbilharzial hyperoxaluria: effect of pyridoxine and allopurinol treatment.
    el-Habet AE; el-Sewedy SM; el-Sharaky A; Gaafar NK; Abdel-Rafee A; Hamoud F
    Biochem Med Metab Biol; 1987 Aug; 38(1):1-8. PubMed ID: 3663392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical results of allopurinol treatment in prevention of calcium oxalate stone formation.
    Tiselius HG; Larsson L; Hellgren E
    J Urol; 1986 Jul; 136(1):50-3. PubMed ID: 3712614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.